BioMérieux team touts development of quicker sepsis Dx approach

Researchers at bioMérieux said they've developed a new, quicker and cheaper way to diagnose sepsis. Their method involves destroying white blood cells within a sample, centrifugation to collect bacteria or fungi from the sample and then fluorescence spectroscopy to analyze the fingerprint of pathogens carried by the sample. They said that their approach correctly identified species of bacteria or fungi in 96.5% of positive blood culture samples. The team said that the current approach to spotting bloodstream infections, which includes Gram staining, overnight subculture and then phenotypic ID tests, can be time-consuming, which often prevents quick treatment. Details of their research are published in mBio, the online open-access journal of the American Society for Microbiology. Item | Journal article

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.